A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pimodivir in Combination with the Standard-of-care Treatment in Adolescent, Adult, and Elderly Hospitalized Patients with Influenza A Infection

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/17/MH/369 (ERM Project ID 38321)
NMA SSA Reference Number: SSA/38321/MonH-2019-166402(v1)
Monash Health Ref: RES-19-0000-146X
Effective start/end date4/04/193/04/24


  • clinical trial
  • phase 3 study
  • influenza
  • treatment efficacy